HOME >> BIOLOGY >> NEWS
Chromosome 'caps' predict bone marrow disease

For the first time, Imperial College London researchers at the Hammersmith Hospital studying a rare bone marrow disease have found an association between 'telomere shortening' - changes in the lengths of DNA repeats at the end of chromosomes - and the time of development and severity of disease symptoms in patients.

Reporting in Nature Genetics today (18 April 2004), the Hammersmith team, collaborating with scientists at the Washington University School of Medicine in the USA, is hoping that the findings could lead to better screening for this and other diseases, as well as suggest targets for new therapies.

Dyskeratosis congenita (DC) is a rare but serious inherited condition where the body is unable to make adequate numbers of blood cells. It can lead to bone marrow failure and a much higher risk of developing cancer. People with DC also have a mutation in an enzyme (telomerase) which repairs telomeres (sections of DNA repeats which 'cap' the ends of chromosomes) and as a result, telomere length in their chromosomes is shorter.

In families with a history of a certain type of the disease, autosomal dominant DC, the disease becomes more severe in succeeding generations. "We found when we looked at the DNA of families that suffer from the disease, the telomere length gave an indication of how soon and how severely patients were likely to get the disease," said Inderjeet Dokal, Professor of Haematology at Imperial College London and one of the authors of the study. "This 'disease anticipation' was only thought to occur in specific neurological diseases until now."

The researchers propose that the shortening of the DNA repeats in telomeres may be responsible for disease anticipation. They investigated the telomere lengths and disease status of 27 affected individuals from eight families with the autosomal dominant sub-type of DC and compared this to telomere length measurements in normal families. "The findings of this study pr
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.ac.uk
44-207-594-6712
Imperial College London
18-Apr-2004


Page: 1 2

Related biology news :

1. Chromosome losses mean poor survival in childhood leukemia
2. Gene-rich human Chromosome 19 sequence completed
3. Chromosomes are nibbled before they fuse, researchers report
4. Chromosome assessment could predict increased risk of death from age-related disease
5. Chromosome centers defined and sequenced for model plant
6. Discovery: Chromosomes Found To End In Big Loops
7. UI Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer
8. Counting X Chromosomes To Determine Sex
9. Genetic Code Of Chromosome Of Malaria Parasite Deciphered
10. Hopkins And International Team Maps First Major Cancer Gene To X Chromosome
11. UNC Scientists Succeed In Inserting Gene In Human Cells Via Artificial Chromosome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/5/2019)... , ... November 05, 2019 , ... ... Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, including porcelain ... of Dental Surgery degree from the University of Washington, Dr. Kopp is passionate ...
(Date:10/30/2019)... BALTIMORE, Md. (PRWEB) , ... October 30, 2019 ... ... at the 12th Annual CBRNe Convergence in Nashville, TN from Tuesday, November 5, ... and military responses to CBRNe (chemical, biological, radiological, nuclear) and IED (explosive) threats. ...
(Date:10/27/2019)... PETERSBURG, Fla. (PRWEB) , ... October 26, 2019 , ... ... and their unique reseller program. By prioritizing the success of their clients, they’ve earned ... three years in a row, and they’ve won many additional awards and accolades along ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... ... to educate Americans about the deadly healthcare-associated infection C. diff. The campaign, ... of the epidemic, which kills at least 30,000 people in the U.S. each ...
(Date:11/5/2019)... ... November 04, 2019 , ... Catalent, ... for drugs, biologics, gene therapies, and consumer health products, today announced the ... enhances Catalent’s proven GPEx expression platform through multiple improvements, including utilization of ...
(Date:11/2/2019)... TORONTO (PRWEB) , ... October 31, 2019 , ... ... at Adaptive Biotechnologies in a live webinar on Friday, ... application in immuno-oncology. , Immunosequencing, the science of profiling T-cell receptors (TCRs) ...
(Date:10/29/2019)... (PRWEB) , ... October 28, 2019 , ... CaroGen ... Board: , , Professor Jack R Wands, MD, of Brown ... Wyeth (Pfizer) , Professor Gil Mor, MD, PhD, of Wayne State University, ...
Breaking Biology Technology:
Cached News: